To Meet Demand, Forma Aims To Boost Discovery Supply
This article was originally published in Start Up
Executive Summary
Forma Therapeutics has already convinced several big industry partners its discovery engine will yield oncology candidates in emerging areas of research. Now it wants to find academic groups to help feed its engine, all while the resurgent biotech IPO market might make its unusual structure superfluous.